Dev Prasad
Stock Analyst at LUCID CAPITAL MARKETS
(2.71)
# 2,101
Out of 5,067 analysts
5
Total ratings
60%
Success rate
23.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dev Prasad
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CUE Cue Biopharma | Initiates: Buy | $4 | $0.59 | +577.74% | 1 | Aug 25, 2025 | |
| IRD Opus Genetics | Initiates: Buy | $5 | $2.00 | +150.00% | 1 | Jun 17, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $24 | $18.00 | +33.33% | 1 | Dec 17, 2024 | |
| IBIO iBio, Inc. | Initiates: Buy | $6 | $1.11 | +440.54% | 1 | Dec 17, 2024 | |
| CALC CalciMedica | Initiates: Buy | $13 | $4.19 | +210.26% | 1 | Dec 17, 2024 |
Cue Biopharma
Aug 25, 2025
Initiates: Buy
Price Target: $4
Current: $0.59
Upside: +577.74%
Opus Genetics
Jun 17, 2025
Initiates: Buy
Price Target: $5
Current: $2.00
Upside: +150.00%
Avalo Therapeutics
Dec 17, 2024
Initiates: Buy
Price Target: $24
Current: $18.00
Upside: +33.33%
iBio, Inc.
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $1.11
Upside: +440.54%
CalciMedica
Dec 17, 2024
Initiates: Buy
Price Target: $13
Current: $4.19
Upside: +210.26%